conivaptan has been researched along with way-151932 in 1 studies
| Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (way-151932) | Trials (way-151932) | Recent Studies (post-2010) (way-151932) |
|---|---|---|---|---|---|
| 188 | 17 | 64 | 6 | 0 | 1 |
| Protein | Taxonomy | conivaptan (IC50) | way-151932 (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.0802 | |
| Oxytocin receptor | Homo sapiens (human) | 0.353 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.08 | |
| Vasopressin V1a receptor | Homo sapiens (human) | 1.072 | |
| Oxytocin receptor | Rattus norvegicus (Norway rat) | 0.055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, JAJ; Bonnet, D; Durroux, T; Frantz, MC; GandÃa, J; Hibert, M; Le Merrer, J; Loison, S; Marsol, C; Mouillac, B; Pellissier, LP; Pflimlin, E; Valencia, C; Villa, P | 1 |
1 other study(ies) available for conivaptan and way-151932
| Article | Year |
|---|---|
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Disease Models, Animal; Female; HEK293 Cells; Humans; Interpersonal Relations; Ligands; Male; Mice; Mice, Knockout; Psychotropic Drugs; Pyrazoles; Pyrrolidines; Receptors, Opioid, mu; Receptors, Oxytocin; Structure-Activity Relationship | 2018 |